• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地塞米松对雄性和雌性大鼠组织纤溶系统的影响。

The effect of dexamethasone on tissue fibrinolytic system in male and female rats.

作者信息

Tsantarliotou M, Taitzoglou I, Kokolis N

机构信息

Department of Physiology, Faculty of Veterinary Medicine, Aristotle University of Thessaloniki, Greece.

出版信息

In Vivo. 1999 Mar-Apr;13(2):119-24.

PMID:10363166
Abstract

BACKGROUND

Dexamethasone in low and high doses affects blood fibrinolytic activity both in animals and humans. In this study the effect of a high dose of dexamethasone on plasminogen activator activity (PAA), t-PA antigen level, plasminogen activator inhibition (PAI) and plasmin inhibition (Pl) in rat heart, brain, liver, lungs and kidneys was investigated in both sexes.

MATERIALS AND METHODS

Twenty male and twenty female adult Wistar rats were used. Dexamethasone was administered as a single intraperitoneal injection (3mg/kg/day) in rats, once daily, for a period of 5 consecutive days. t-PA antigen level was assayed by an enzyme-linked immunoabsorbant assay method. PAA, PAI and Pl were determined by spectrophotometric methods. The plasminogen used was isolated from rat plasma.

RESULTS

Dexamethasone induced variable changes in the fibrinolytic parameters in rat heart, brain and liver of both sexes; in lungs and kidneys dexamethasone had no effect.

CONCLUSION

These changes of PAA, PAI and t-PA antigen level in heart, brain and liver induced by dexamethasone might be of importance regarding the involvement of glucocorticoids and plasminogen activators/plasmin in many pathophysiological conditions.

摘要

背景

低剂量和高剂量地塞米松对动物和人类的血液纤维蛋白溶解活性均有影响。在本研究中,对雄性和雌性大鼠的心脏、大脑、肝脏、肺和肾脏中高剂量地塞米松对纤溶酶原激活物活性(PAA)、组织型纤溶酶原激活物抗原水平(t-PA)、纤溶酶原激活物抑制物(PAI)和纤溶酶抑制物(Pl)的影响进行了研究。

材料与方法

使用20只雄性和20只雌性成年Wistar大鼠。大鼠腹腔注射地塞米松(3mg/kg/天),每日1次,连续5天。采用酶联免疫吸附测定法检测t-PA抗原水平。通过分光光度法测定PAA、PAI和Pl。所用纤溶酶原从大鼠血浆中分离。

结果

地塞米松在雄性和雌性大鼠的心脏、大脑和肝脏中诱导了纤维蛋白溶解参数的不同变化;在肺和肾脏中,地塞米松没有影响。

结论

地塞米松诱导的心脏、大脑和肝脏中PAA、PAI和t-PA抗原水平的这些变化,可能在糖皮质激素和纤溶酶原激活物/纤溶酶参与多种病理生理状况方面具有重要意义。

相似文献

1
The effect of dexamethasone on tissue fibrinolytic system in male and female rats.地塞米松对雄性和雌性大鼠组织纤溶系统的影响。
In Vivo. 1999 Mar-Apr;13(2):119-24.
2
Circadian variations of plasminogen activator activity, tissue-type plasminogen activator antigen, plasminogen activator inhibition and plasmin inhibition in rat aorta, heart and brain are influenced by endotoxin or aspirin or endotoxin plus aspirin.大鼠主动脉、心脏和大脑中纤溶酶原激活物活性、组织型纤溶酶原激活物抗原、纤溶酶原激活物抑制物及纤溶酶抑制物的昼夜变化受内毒素、阿司匹林或内毒素加阿司匹林的影响。
Haemostasis. 1995 May-Jun;25(3):106-13. doi: 10.1159/000217149.
3
Variable response of tissue parameters of the fibrinolytic system to unilateral or bilateral adrenalectomy and unilateral or bilateral adrenal demedullation.纤溶系统组织参数对单侧或双侧肾上腺切除术以及单侧或双侧肾上腺髓质剥脱术的可变反应。
J Endocrinol Invest. 1991 Nov;14(10):815-20. doi: 10.1007/BF03347934.
4
Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.维甲酸通过增强组织型纤溶酶原激活剂(t-PA)的活性来提高体内纤溶活性,并抑制静脉血栓形成。
Thromb Haemost. 1993 Apr 1;69(4):381-6.
5
Effect of growth hormone on fibrinolytic system in rat.生长激素对大鼠纤溶系统的影响。
Indian J Exp Biol. 1998 May;36(5):514-6.
6
Dexamethasone inhibition of tissue-type plasminogen activator (tPA) activity: paradoxical induction of both tPA antigen and plasminogen activator inhibitor.
Mol Endocrinol. 1987 Jan;1(1):97-101. doi: 10.1210/mend-1-1-97.
7
Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.兔组织提取物中纤溶成分的新型分布模式:一项初步研究。
J Zhejiang Univ Sci B. 2007 Aug;8(8):570-4. doi: 10.1631/jzus.2007.B0570.
8
Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients.环孢素A治疗患者龈沟液中的纤溶酶原激活剂和纤溶酶原激活剂抑制剂
J Clin Periodontol. 2004 Jul;31(7):556-61. doi: 10.1111/j.1600-051X.2004.00517.x.
9
Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole.用野百合碱吡咯处理的大鼠血液和肺中的纤溶活性。
Toxicol Appl Pharmacol. 1993 Jul;121(1):129-37. doi: 10.1006/taap.1993.1137.
10
Impairment of the blood-brain barrier: a potential surrogate delineating the determinants of cerebral bleeding caused by fibrinolytic drugs.血脑屏障受损:一种描绘纤溶药物所致脑出血决定因素的潜在替代指标。
Coron Artery Dis. 1999 Sep;10(6):413-20.